New horizons in multimodality molecular imaging and novel radiotracers

Sally Barrington; Philip Blower; Gary Cook

doi:10.7861/clinmedicine.17-5-444

New horizons in multimodality molecular imaging and novel radiotracers

GSTT Guy's and St Thomas' NHS Foundation Trust
Department of Cancer Imaging and Guy's & St Thomas' PET Centre, King's College London, London, UK [email protected].

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

52 Downloads (Pure)

Abstract

Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes.

Original language	English
Pages (from-to)	444-448
Number of pages	5
Journal	Clinical Medicine
Volume	17
Issue number	5
DOIs	https://doi.org/10.7861/clinmedicine.17-5-444
Publication status	Published - 1 Oct 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.7861/clinmedicine.17-5-444

New horizons in multimodality_BARRINGTON_Published1October2017_GREEN AAMAccepted author manuscript, 2.24 MB

Cite this

@article{2620170e9bc44405b43f45c772462aed,

title = "New horizons in multimodality molecular imaging and novel radiotracers",

abstract = "Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes.",

author = "Sally Barrington and Philip Blower and Gary Cook",

year = "2017",

month = oct,

day = "1",

doi = "10.7861/clinmedicine.17-5-444",

language = "English",

volume = "17",

pages = "444--448",

journal = "Clinical Medicine",

issn = "1470-2118",

publisher = "MDPI AG",

number = "5",

}

TY - JOUR

T1 - New horizons in multimodality molecular imaging and novel radiotracers

AU - Barrington, Sally

AU - Blower, Philip

AU - Cook, Gary

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes.

AB - Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes.

U2 - 10.7861/clinmedicine.17-5-444

DO - 10.7861/clinmedicine.17-5-444

M3 - Article

C2 - 28974596

SN - 1470-2118

VL - 17

SP - 444

EP - 448

JO - Clinical Medicine

JF - Clinical Medicine

IS - 5

ER -

New horizons in multimodality molecular imaging and novel radiotracers

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this